Helix BioPharma Corp.

TSX:HBP.TO

0.95 (CAD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 0000000000004.264.5324.4343.8413.5913.424
Cost of Revenue 0.0140.0130.0120.1730.2120.0560.1670.130.1340001.7411.6421.6691.5161.2391.139
Gross Profit -0.014-0.013-0.012-0.173-0.212-0.056-0.167-0.13-0.1340002.5192.892.7652.3252.3522.285
Gross Profit Ratio 0000000000000.5910.6380.6240.6050.6550.667
Reseach & Development Expenses 6.0955.2814.5445.885.8685.0066.0847.0555.8214.8855.2395.0327.457.32310.71510.3225.0644.116
General & Administrative Expenses 00.2990.5953.2482.7192.4692.4363.2073.8363.8923.4963.1964.586.5164.4514.944.8014.465
Selling & Marketing Expenses 0000000000001.0881.1241.1250.96900
SG&A 3.2620.2990.5953.2482.7192.4692.4363.2073.8363.8923.4963.1965.6687.645.5765.9094.8014.465
Other Expenses 0-0.0590.9010.0030.0290.0170.0260000000.4040.3820.3840.271.778
Operating Expenses 9.3576.3266.049.1318.6167.4928.54610.2629.6578.7778.7358.22813.11815.36716.67316.61510.13510.359
Operating Income -9.371-6.279-6.537-9.611-8.591-7.489-8.537-10.246-9.631-8.721-8.692-8.178-10.599-12.477-13.344-14.059-8.11-6.751
Operating Income Ratio 000000000000-2.488-2.753-3.009-3.66-2.258-1.972
Total Other Income Expenses Net -0.0250.036-0.523-0.4430.055-0.158-0.0790.035-0.008-0.0030.0530.016-7.5031.456-0.4680.2060.9720.505
Income Before Tax -9.396-6.29-6.564-9.574-8.561-7.526-8.625-10.059-9.665-8.78-8.682-8.194-17.423-11.014-14.423-14.084-6.811-7.569
Income Before Tax Ratio 000000000000-4.09-2.43-3.253-3.667-1.897-2.211
Income Tax Expense -0.1320.014-0.484-1.6630.4490.0010.0290.0140.017-0.0370.019-6.6240.0170.3340.0460.0180.1530.105
Net Income -9.264-6.29-6.08-7.911-9.01-7.527-8.654-10.073-9.682-8.743-8.701-1.57-17.44-11.348-14.469-14.102-6.964-7.674
Net Income Ratio 000000000000-4.094-2.504-3.263-3.671-1.939-2.241
EPS -0.21-0.163-0.204-0.287-0.353-0.353-0.433-0.55-0.55-0.55-0.6-0.117-1.3-0.85-1.2-1.35-0.8-1.1
EPS Diluted -0.21-0.163-0.204-0.287-0.353-0.353-0.433-0.55-0.55-0.55-0.6-0.117-1.3-0.85-1.2-1.35-0.8-1.1
EBITDA -9.375-6.313-6.028-9.461-8.444-6.719-8.59-10.132-9.523-8.644-8.003-7.832-17.403-12.246-13.994-13.906-7.513-7.123
EBITDA Ratio 000000000000-4.085-2.702-3.156-3.62-2.092-2.08